Why investors love China's loss-making health startups

No profit, no problem: a string of Chinese healthcare firms are riding momentum from strong policy support and a vast consumer market all the way to IPOs. But it's not too late to find a good deal.

Why investors love China's loss-making health startups

Why would scores of investors from across the world want to pile into loss-making companies in a sector that is at the mercy of China's notoriously unpredictable regulators There are 1.3 billion good reasons.

The world's most populous nation is pushing hard to revamp a health sector that has long struggled with an imbalance between growing patient numbers and limited resources. China's growing middle class is demanding better healthcare and the country's leadership, ever mindful...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Print Edition

FinanceAsia Print Edition